MARINUS PHARMACEUTICALS, INC. Proceeds from Issuance Initial Public Offering
MARINUS PHARMACEUTICALS, INC. reported Proceeds from Issuance Initial Public Offering of -$167.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-03-13
- MARINUS PHARMACEUTICALS, INC. proceeds from issuance initial public offering for the quarter ending 2014-12-31 was -$470.00K.
- MARINUS PHARMACEUTICALS, INC. proceeds from issuance initial public offering for the quarter ending 2014-09-30 was $41.20M.
- MARINUS PHARMACEUTICALS, INC. proceeds from issuance initial public offering for fiscal 2016 was -$167.00K, a 100.59% decline from fiscal 2015.
- MARINUS PHARMACEUTICALS, INC. proceeds from issuance initial public offering for fiscal 2015 was $28.28M, a 31.37% decline from fiscal 2014.
- MARINUS PHARMACEUTICALS, INC. proceeds from issuance initial public offering for fiscal 2014 was $41.20M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 9 month as first filed | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | -$167.00K 10-K · filed 2017-03-13 | ||||
| 2015-12-31 | $28.28M 10-K · filed 2017-03-13 | ||||
| 2014-12-31 | -$470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $40.73M derived: sum of 2 quarters · filed 2017-03-13 | $41.20M 10-K · filed 2017-03-13 | ||
| 2014-09-30 | $41.20M 10-Q · filed 2015-10-29 | $41.67M 10-Q · filed 2015-10-29 | $41.67M 10-Q · filed 2014-11-13 |